Report Detail

Service & Software Global Clinical Trial Management Software (CTMS) Market Size, Status and Forecast 2019-2025

  • RnM3218040
  • |
  • 29 May, 2020
  • |
  • Global
  • |
  • 103 Pages
  • |
  • QYResearch
  • |
  • Service & Software

This report covers market size and forecasts of Clinical Trial Management Software (CTMS), including the following market information:
Global Clinical Trial Management Software (CTMS) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Clinical Trial Management Software (CTMS) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Clinical Trial Management Software (CTMS) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Clinical Trial Management Software (CTMS) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Castor, Abbott Informatics, Medrio, Flex Databases, Integrated Clinical Solutions, MedSciNet, Clinion, Qlik, OpenClinica, Xybion, Perficient, Appistry, Cambridge Cognition, Viedoc, EAdjudication, SimpleTrials, MasterControl, Bio-Optronics, ClinPlus, Dacima Software, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Web-based CTMS
Licensed Enterprise (On-premise) CTMS
Cloud-based (SaaS) CTMS

Based on the Application:
Hospitals
Clinics
Other


  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Clinical Trial Management Software (CTMS) Industry
  • 1.7 COVID-19 Impact: Clinical Trial Management Software (CTMS) Market Trends
  • 2 Global Clinical Trial Management Software (CTMS) Quarterly Market Size Analysis

    • 2.1 Clinical Trial Management Software (CTMS) Business Impact Assessment - COVID-19
      • 2.1.1 Global Clinical Trial Management Software (CTMS) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Clinical Trial Management Software (CTMS) Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Clinical Trial Management Software (CTMS) Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Clinical Trial Management Software (CTMS) Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Clinical Trial Management Software (CTMS) Market
    • 3.4 Key Players Clinical Trial Management Software (CTMS) Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Clinical Trial Management Software (CTMS) Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Web-based CTMS
      • 1.4.2 Licensed Enterprise (On-premise) CTMS
      • 1.4.3 Cloud-based (SaaS) CTMS
    • 4.2 By Type, Global Clinical Trial Management Software (CTMS) Market Size, 2019-2021

    5 Impact of Covid-19 on Clinical Trial Management Software (CTMS) Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Clinics
      • 5.5.3 Other
    • 5.2 By Application, Global Clinical Trial Management Software (CTMS) Market Size, 2019-2021
      • 5.2.1 By Application, Global Clinical Trial Management Software (CTMS) Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Castor
      • 7.1.1 Castor Business Overview
      • 7.1.2 Castor Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.1.3 Castor Clinical Trial Management Software (CTMS) Product Introduction
      • 7.1.4 Castor Response to COVID-19 and Related Developments
    • 7.2 Abbott Informatics
      • 7.2.1 Abbott Informatics Business Overview
      • 7.2.2 Abbott Informatics Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.2.3 Abbott Informatics Clinical Trial Management Software (CTMS) Product Introduction
      • 7.2.4 Abbott Informatics Response to COVID-19 and Related Developments
    • 7.3 Medrio
      • 7.3.1 Medrio Business Overview
      • 7.3.2 Medrio Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.3.3 Medrio Clinical Trial Management Software (CTMS) Product Introduction
      • 7.3.4 Medrio Response to COVID-19 and Related Developments
    • 7.4 Flex Databases
      • 7.4.1 Flex Databases Business Overview
      • 7.4.2 Flex Databases Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.4.3 Flex Databases Clinical Trial Management Software (CTMS) Product Introduction
      • 7.4.4 Flex Databases Response to COVID-19 and Related Developments
    • 7.5 Integrated Clinical Solutions
      • 7.5.1 Integrated Clinical Solutions Business Overview
      • 7.5.2 Integrated Clinical Solutions Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.5.3 Integrated Clinical Solutions Clinical Trial Management Software (CTMS) Product Introduction
      • 7.5.4 Integrated Clinical Solutions Response to COVID-19 and Related Developments
    • 7.6 MedSciNet
      • 7.6.1 MedSciNet Business Overview
      • 7.6.2 MedSciNet Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.6.3 MedSciNet Clinical Trial Management Software (CTMS) Product Introduction
      • 7.6.4 MedSciNet Response to COVID-19 and Related Developments
    • 7.7 Clinion
      • 7.7.1 Clinion Business Overview
      • 7.7.2 Clinion Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.7.3 Clinion Clinical Trial Management Software (CTMS) Product Introduction
      • 7.7.4 Clinion Response to COVID-19 and Related Developments
    • 7.8 Qlik
      • 7.8.1 Qlik Business Overview
      • 7.8.2 Qlik Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.8.3 Qlik Clinical Trial Management Software (CTMS) Product Introduction
      • 7.8.4 Qlik Response to COVID-19 and Related Developments
    • 7.9 OpenClinica
      • 7.9.1 OpenClinica Business Overview
      • 7.9.2 OpenClinica Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.9.3 OpenClinica Clinical Trial Management Software (CTMS) Product Introduction
      • 7.9.4 OpenClinica Response to COVID-19 and Related Developments
    • 7.10 Xybion
      • 7.10.1 Xybion Business Overview
      • 7.10.2 Xybion Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.10.3 Xybion Clinical Trial Management Software (CTMS) Product Introduction
      • 7.10.4 Xybion Response to COVID-19 and Related Developments
    • 7.11 Perficient
      • 7.11.1 Perficient Business Overview
      • 7.11.2 Perficient Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.11.3 Perficient Clinical Trial Management Software (CTMS) Product Introduction
      • 7.11.4 Perficient Response to COVID-19 and Related Developments
    • 7.12 Appistry
      • 7.12.1 Appistry Business Overview
      • 7.12.2 Appistry Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.12.3 Appistry Clinical Trial Management Software (CTMS) Product Introduction
      • 7.12.4 Appistry Response to COVID-19 and Related Developments
    • 7.13 Cambridge Cognition
      • 7.13.1 Cambridge Cognition Business Overview
      • 7.13.2 Cambridge Cognition Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.13.3 Cambridge Cognition Clinical Trial Management Software (CTMS) Product Introduction
      • 7.13.4 Cambridge Cognition Response to COVID-19 and Related Developments
    • 7.14 Viedoc
      • 7.14.1 Viedoc Business Overview
      • 7.14.2 Viedoc Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.14.3 Viedoc Clinical Trial Management Software (CTMS) Product Introduction
      • 7.14.4 Viedoc Response to COVID-19 and Related Developments
    • 7.15 EAdjudication
      • 7.15.1 EAdjudication Business Overview
      • 7.15.2 EAdjudication Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.15.3 EAdjudication Clinical Trial Management Software (CTMS) Product Introduction
      • 7.15.4 EAdjudication Response to COVID-19 and Related Developments
    • 7.16 SimpleTrials
      • 7.16.1 SimpleTrials Business Overview
      • 7.16.2 SimpleTrials Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.16.3 SimpleTrials Clinical Trial Management Software (CTMS) Product Introduction
      • 7.16.4 SimpleTrials Response to COVID-19 and Related Developments
    • 7.17 MasterControl
      • 7.17.1 MasterControl Business Overview
      • 7.17.2 MasterControl Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.17.3 MasterControl Clinical Trial Management Software (CTMS) Product Introduction
      • 7.17.4 MasterControl Response to COVID-19 and Related Developments
    • 7.18 Bio-Optronics
      • 7.18.1 Bio-Optronics Business Overview
      • 7.18.2 Bio-Optronics Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.18.3 Bio-Optronics Clinical Trial Management Software (CTMS) Product Introduction
      • 7.18.4 Bio-Optronics Response to COVID-19 and Related Developments
    • 7.19 ClinPlus
      • 7.19.1 ClinPlus Business Overview
      • 7.19.2 ClinPlus Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.19.3 ClinPlus Clinical Trial Management Software (CTMS) Product Introduction
      • 7.19.4 ClinPlus Response to COVID-19 and Related Developments
    • 7.20 Dacima Software
      • 7.20.1 Dacima Software Business Overview
      • 7.20.2 Dacima Software Clinical Trial Management Software (CTMS) Quarterly Revenue, 2020
      • 7.20.3 Dacima Software Clinical Trial Management Software (CTMS) Product Introduction
      • 7.20.4 Dacima Software Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      Summary:
      Get latest Market Research Reports on Clinical Trial Management Software (CTMS) . Industry analysis & Market Report on Clinical Trial Management Software (CTMS) is a syndicated market report, published as Global Clinical Trial Management Software (CTMS) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Clinical Trial Management Software (CTMS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,250.00
      $4,875.00
      $6,500.00
      2,570.75
      3,856.13
      5,141.50
      2,996.50
      4,494.75
      5,993.00
      504,725.00
      757,087.50
      1,009,450.00
      271,375.00
      407,062.50
      542,750.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report